Kanchan Bisht, MS - Related publications

2009-2012 National Brain Research Centre, Gurugram, Haryana, India 
 2012-2014 ETH Zürich, Brain Research Institute 
 2014-2018 Molecular Medicine Université Laval, Ville de Québec, Québec, Canada 
Microglia, Dark microglia, Stress, Spinal cord injury, stroke
NOTE: We are testing a new system for identifying relevant work based on semantic analysis that identifies similarities between recently published papers and the current author's publications. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches.
50 most relevant papers in past 60 days:
Year Citation  Score
2021 Rossi B, Santos-Lima B, Terrabuio E, Zenaro E, Constantin G. Common Peripheral Immunity Mechanisms in Multiple Sclerosis and Alzheimer's Disease. Frontiers in Immunology. 12: 639369. PMID 33679799 DOI: 10.3389/fimmu.2021.639369   
2021 Ni J, Wu Z. Inflammation Spreading: Negative Spiral Linking Systemic Inflammatory Disorders and Alzheimer's Disease. Frontiers in Cellular Neuroscience. 15: 638686. PMID 33716675 DOI: 10.3389/fncel.2021.638686   
2021 Acioglu C, Li L, Elkabes S. Contribution of astrocytes to neuropathology of neurodegenerative diseases. Brain Research. 147291. PMID 33516810 DOI: 10.1016/j.brainres.2021.147291   
2021 Hartnell IJ, Blum D, Nicoll JAR, Dorothee G, Boche D. Glial cells and adaptive immunity in frontotemporal dementia with tau pathology. Brain : a Journal of Neurology. PMID 33527991 DOI: 10.1093/brain/awaa457   
2021 Tauffenberger A, Magistretti PJ. Reactive Oxygen Species: Beyond Their Reactive Behavior. Neurochemical Research. 46: 77-87. PMID 33439432 DOI: 10.1007/s11064-020-03208-7   
2021 Lau JKY, Tian M, Shen Y, Lau SF, Fu WY, Fu AKY, Ip NY. Melanocortin receptor activation alleviates amyloid pathology and glial reactivity in an Alzheimer's disease transgenic mouse model. Scientific Reports. 11: 4359. PMID 33623128 DOI: 10.1038/s41598-021-83932-4   
2021 Smit T, Deshayes NAC, Borchelt DR, Kamphuis W, Middeldorp J, Hol EM. Reactive astrocytes as treatment targets in Alzheimer's disease-Systematic review of studies using the APPswePS1dE9 mouse model. Glia. PMID 33634529 DOI: 10.1002/glia.23981   
2021 Price BR, Johnson LA, Norris CM. Reactive Astrocytes: The nexus of pathological and clinical hallmarks of Alzheimer's disease. Ageing Research Reviews. 101335. PMID 33812051 DOI: 10.1016/j.arr.2021.101335   
2021 Maeda J, Minamihisamatsu T, Shimojo M, Zhou X, Ono M, Matsuba Y, Ji B, Ishii H, Ogawa M, Akatsu H, Kaneda D, Hashizume Y, Robinson JL, Lee VM, Saito T, et al. Distinct microglial response against Alzheimer's amyloid and tau pathologies characterized by P2Y12 receptor. Brain Communications. 3: fcab011. PMID 33644757 DOI: 10.1093/braincomms/fcab011   
2021 Wang C, Xiong M, Gratuze M, Bao X, Shi Y, Andhey PS, Manis M, Schroeder C, Yin Z, Madore C, Butovsky O, Artyomov M, Ulrich JD, Holtzman DM. Selective removal of astrocytic APOE4 strongly protects against tau-mediated neurodegeneration and decreases synaptic phagocytosis by microglia. Neuron. PMID 33831349 DOI: 10.1016/j.neuron.2021.03.024   
2021 Wang C, Xiong M, Gratuze M, Bao X, Shi Y, Andhey PS, Manis M, Schroeder C, Yin Z, Madore C, Butovsky O, Artyomov M, Ulrich JD, Holtzman DM. Selective removal of astrocytic APOE4 strongly protects against tau-mediated neurodegeneration and decreases synaptic phagocytosis by microglia. Neuron. PMID 33831349 DOI: 10.1016/j.neuron.2021.03.024   
2021 Davis N, Mota BC, Stead L, Palmer EOC, Lombardero L, Rodríguez-Puertas R, de Paola V, Barnes SJ, Sastre M. Pharmacological ablation of astrocytes reduces Aβ degradation and synaptic connectivity in an ex vivo model of Alzheimer's disease. Journal of Neuroinflammation. 18: 73. PMID 33731156 DOI: 10.1186/s12974-021-02117-y   
2021 Ungerleider K, Beck J, Lissa D, Turnquist C, Horikawa I, Harris BT, Harris CC. Astrocyte senescence and SASP in neurodegeneration: tau joins the loop. Cell Cycle (Georgetown, Tex.). 1-13. PMID 33818291 DOI: 10.1080/15384101.2021.1909260   
2021 Chen MJ, Ramesha S, Weinstock LD, Gao T, Ping L, Xiao H, Dammer EB, Duong DD, Levey AI, Lah JJ, Seyfried NT, Wood LB, Rangaraju S. Extracellular signal-regulated kinase regulates microglial immune responses in Alzheimer's disease. Journal of Neuroscience Research. PMID 33729626 DOI: 10.1002/jnr.24829   
2021 Suresh P, Phasuk S, Liu IY. Modulation of microglia activation and Alzheimer's disease: CX3 chemokine ligand 1/CX3CR and P2XR signaling. Tzu Chi Medical Journal. 33: 1-6. PMID 33505871 DOI: 10.4103/tcmj.tcmj_144_20   
2021 Song L, Wells EA, Robinson AS. Critical Molecular and Cellular Contributors to Tau Pathology. Biomedicines. 9. PMID 33672982 DOI: 10.3390/biomedicines9020190   
2021 Kushwaha R, Sinha A, Makarava N, Molesworth K, Baskakov IV. Non-cell autonomous astrocyte-mediated neuronal toxicity in prion diseases. Acta Neuropathologica Communications. 9: 22. PMID 33546775 DOI: 10.1186/s40478-021-01123-8   
2021 Fairley LH, Wong JH, Barron AM. Mitochondrial Regulation of Microglial Immunometabolism in Alzheimer's Disease. Frontiers in Immunology. 12: 624538. PMID 33717134 DOI: 10.3389/fimmu.2021.624538   
2021 Derkinderen P, Rolli-Derkinderen M, Chapelet G, Neunlist M, Noble W. Tau in the gut, does it really matter? Journal of Neurochemistry. PMID 33569813 DOI: 10.1111/jnc.15320   
2021 Bourgognon JM, Spiers JG, Robinson SW, Scheiblich H, Glynn P, Ortori C, Bradley SJ, Tobin AB, Steinert JR. Inhibition of neuroinflammatory nitric oxide signaling suppresses glycation and prevents neuronal dysfunction in mouse prion disease. Proceedings of the National Academy of Sciences of the United States of America. 118. PMID 33653950 DOI: 10.1073/pnas.2009579118   
2021 Clayton K, Delpech JC, Herron S, Iwahara N, Ericsson M, Saito T, Saido TC, Ikezu S, Ikezu T. Plaque associated microglia hyper-secrete extracellular vesicles and accelerate tau propagation in a humanized APP mouse model. Molecular Neurodegeneration. 16: 18. PMID 33752701 DOI: 10.1186/s13024-021-00440-9   
2021 Ding Q, Shults NV, Gychka SG, Harris BT, Suzuki YJ. Protein Expression of Angiotensin-Converting Enzyme 2 (ACE2) is Upregulated in Brains with Alzheimer's Disease. International Journal of Molecular Sciences. 22. PMID 33567524 DOI: 10.3390/ijms22041687   
2021 Potter H, Woodcock JH, Boyd TD, Coughlan CM, O'Shaughnessy JR, Borges MT, Thaker AA, Raj BA, Adamszuk K, Scott D, Adame V, Anton P, Chial HJ, Gray H, Daniels J, et al. Safety and efficacy of sargramostim (GM-CSF) in the treatment of Alzheimer's disease. Alzheimer's & Dementia (New York, N. Y.). 7: e12158. PMID 33778150 DOI: 10.1002/trc2.12158   
2021 Nackenoff AG, Hohman TJ, Neuner SM, Akers CS, Weitzel NC, Shostak A, Ferguson SM, Mobley B, Bennett DA, Schneider JA, Jefferson AL, Kaczorowski CC, Schrag MS. PLD3 is a neuronal lysosomal phospholipase D associated with β-amyloid plaques and cognitive function in Alzheimer's disease. Plos Genetics. 17: e1009406. PMID 33830999 DOI: 10.1371/journal.pgen.1009406   
2021 Bachstetter AD, Garrett FG, Jicha GA, Nelson PT. Space-occupying brain lesions, trauma-related tau astrogliopathy, and ARTAG: a report of two cases and a literature review. Acta Neuropathologica Communications. 9: 49. PMID 33757579 DOI: 10.1186/s40478-021-01152-3   
2021 Tian DY, Cheng Y, Zhuang ZQ, He CY, Pan QG, Tang MZ, Hu XL, Shen YY, Wang YR, Chen SH, Sun HL, Sun PY, Yu ZY, Fan DY, Bu XL, et al. Physiological clearance of amyloid-beta by the kidney and its therapeutic potential for Alzheimer's disease. Molecular Psychiatry. PMID 33828237 DOI: 10.1038/s41380-021-01073-6   
2021 Liang HY, Zhang PP, Zhang XL, Zheng YY, Huang YR, Zheng GQ, Lin Y. Preclinical systematic review of ginsenoside Rg1 for cognitive impairment in Alzheimer's disease. Aging. 13. PMID 33686024 DOI: 10.18632/aging.202619   
2021 Harcha PA, Garcés P, Arredondo C, Fernández G, Sáez JC, van Zundert B. Mast Cell and Astrocyte Hemichannels and Their Role in Alzheimer's Disease, ALS, and Harmful Stress Conditions. International Journal of Molecular Sciences. 22. PMID 33672031 DOI: 10.3390/ijms22041924   
2021 Thammisetty SS, Renaud L, Picher-Martel V, Weng YC, Calon F, Saikali S, Julien JP, Kriz J. Targeting TDP-43 Pathology Alleviates Cognitive and Motor Deficits Caused by Chronic Cerebral Hypoperfusion. Neurotherapeutics : the Journal of the American Society For Experimental Neurotherapeutics. PMID 33786804 DOI: 10.1007/s13311-021-01015-8   
2021 González-Molina LA, Villar-Vesga J, Henao-Restrepo J, Villegas A, Lopera F, Cardona-Gómez GP, Posada-Duque R. Extracellular Vesicles From 3xTg-AD Mouse and Alzheimer's Disease Patient Astrocytes Impair Neuroglial and Vascular Components. Frontiers in Aging Neuroscience. 13: 593927. PMID 33679370 DOI: 10.3389/fnagi.2021.593927   
2021 Jiang N, Cupolillo D, Grosjean N, Muller E, Deforges S, Mulle C, Amédée T. Impaired plasticity of intrinsic excitability in the dentate gyrus alters spike transfer in a mouse model of Alzheimer's disease. Neurobiology of Disease. 105345. PMID 33766653 DOI: 10.1016/j.nbd.2021.105345   
2021 Singh YP, Rai H, Singh G, Singh GK, Mishra S, Kumar S, Srikrishna S, Modi G. A review on ferulic acid and analogs based scaffolds for the management of Alzheimer's disease. European Journal of Medicinal Chemistry. 215: 113278. PMID 33662757 DOI: 10.1016/j.ejmech.2021.113278   
2021 Tahira A, Marques F, Lisboa B, Feltrin A, Barbosa A, de Oliveira KC, de Bragança Pereira CA, Leite R, Grinberg L, Suemoto C, de Lucena Ferretti-Rebustini RE, Pasqualucci CA, Jacob-Filho W, Brentani H, Palha JA. Are the 50's, the transition decade, in choroid plexus aging? Geroscience. PMID 33576945 DOI: 10.1007/s11357-021-00329-x   
2021 Guennewig B, Lim J, Marshall L, McCorkindale AN, Paasila PJ, Patrick E, Kril JJ, Halliday GM, Cooper AA, Sutherland GT. Defining early changes in Alzheimer's disease from RNA sequencing of brain regions differentially affected by pathology. Scientific Reports. 11: 4865. PMID 33649380 DOI: 10.1038/s41598-021-83872-z   
2021 Arber C, Alatza A, Leckey CA, Paterson RW, Zetterberg H, Wray S. Mass spectrometry analysis of tau and amyloid-beta in iPSC-derived models of Alzheimer's disease and dementia. Journal of Neurochemistry. PMID 33539581 DOI: 10.1111/jnc.15315   
2021 Chang CW, Shao E, Mucke L. Tau: Enabler of diverse brain disorders and target of rapidly evolving therapeutic strategies. Science (New York, N.Y.). 371. PMID 33632820 DOI: 10.1126/science.abb8255   
2021 Elmazoglu Z, Galván-Arzate S, Aschner M, Rangel-López E, Bayraktar O, Santamaría A, Karasu Ç. Redox-active phytoconstituents ameliorate cell damage and inflammation in rat hippocampal neurons exposed to hyperglycemia+Aβ peptide. Neurochemistry International. 145: 104993. PMID 33610590 DOI: 10.1016/j.neuint.2021.104993   
2021 Ramanan VK, Lesnick TG, Przybelski SA, Heckman MG, Knopman DS, Graff-Radford J, Lowe VJ, Machulda MM, Mielke MM, Jack CR, Petersen RC, Ross OA, Vemuri P, . Coping with brain amyloid: genetic heterogeneity and cognitive resilience to Alzheimer's pathophysiology. Acta Neuropathologica Communications. 9: 48. PMID 33757599 DOI: 10.1186/s40478-021-01154-1   
2021 Butler CA, Popescu A, Kitchener E, Allendorf DH, Puigdellívol M, Brown GC. Microglial phagocytosis of neurons in neurodegeneration, and its regulation. Journal of Neurochemistry. PMID 33608912 DOI: 10.1111/jnc.15327   
2021 Haddad M, Hervé V, Ben Khedher MR, Rabanel JM, Ramassamy C. Glutathione: an old and small molecule with great functions and new applications in the brain and in Alzheimer's disease. Antioxidants & Redox Signaling. PMID 33637005 DOI: 10.1089/ars.2020.8129   
2021 Gu X, Zhou J, Zhou Y, Wang H, Si N, Ren W, Zhao W, Fan X, Gao W, Wei X, Yang J, Bian B, Zhao H. Huanglian Jiedu decoction remodels the periphery microenvironment to inhibit Alzheimer's disease progression based on the "brain-gut" axis through multiple integrated omics. Alzheimer's Research & Therapy. 13: 44. PMID 33579351 DOI: 10.1186/s13195-021-00779-7   
2021 Holbrook JA, Jarosz-Griffiths HH, Caseley E, Lara-Reyna S, Poulter JA, Williams-Gray CH, Peckham D, McDermott MF. Neurodegenerative Disease and the NLRP3 Inflammasome. Frontiers in Pharmacology. 12: 643254. PMID 33776778 DOI: 10.3389/fphar.2021.643254   
2021 Soto-Rojas LO, Pacheco-Herrero M, Martínez-Gómez PA, Campa-Córdoba BB, Apátiga-Pérez R, Villegas-Rojas MM, Harrington CR, de la Cruz F, Garcés-Ramírez L, Luna-Muñoz J. The Neurovascular Unit Dysfunction in Alzheimer's Disease. International Journal of Molecular Sciences. 22. PMID 33670754 DOI: 10.3390/ijms22042022   
2021 Zhang PF, Hu H, Tan L, Yu JT. Microglia Biomarkers in Alzheimer's Disease. Molecular Neurobiology. PMID 33713018 DOI: 10.1007/s12035-021-02348-3   
2021 Jiang Y, Li K, Li X, Xu L, Yang Z. Sodium butyrate ameliorates the impairment of synaptic plasticity by inhibiting the neuroinflammation in 5XFAD mice. Chemico-Biological Interactions. 109452. PMID 33785315 DOI: 10.1016/j.cbi.2021.109452   
2021 Kwon OC, Song JJ, Yang Y, Kim SH, Kim JY, Seok MJ, Hwang I, Yu JW, Karmacharya J, Maeng HJ, Kim J, Jho EH, Ko SY, Son H, Chang MY, et al. SGK1 inhibition in glia ameliorates pathologies and symptoms in Parkinson disease animal models. Embo Molecular Medicine. e13076. PMID 33646633 DOI: 10.15252/emmm.202013076   
2021 Das M, Devi KP. Dihydroactinidiolide regulates Nrf2/HO-1 expression and inhibits caspase-3/Bax pathway to protect SH-SY5Y human neuroblastoma cells from oxidative stress induced neuronal apoptosis. Neurotoxicology. PMID 33617922 DOI: 10.1016/j.neuro.2021.02.006   
2021 Akter R, Rahman MH, Behl T, Chowdhury MAR, Manirujjaman M, Bulbul IJ, Elshenaw SE, Tit DM, Bungau S. Prospective Role of Polyphenolic Compounds in the Treatment of Neurodegenerative Diseases. Cns & Neurological Disorders Drug Targets. PMID 33602109 DOI: 10.2174/1871527320666210218084444   
2021 Qu Y, Wang W, Chen T, Yang Y, Zhang Y, Wang D. The neuroprotection of deproteinized calf blood extractives injection against Alzheimer's disease via regulation of Nrf-2 signaling. Aging. 13. PMID 33819182 DOI: 10.18632/aging.202776   
2021 Hao F, Feng Y. Bulbocodin D ameliorate cognitive impairment in APP/PS1 transgenic mice by modulating amyloid-beta burden, oxidative status and neuroinflammation. Psychopharmacology. PMID 33811504 DOI: 10.1007/s00213-021-05832-9